Provided by Tiger Trade Technology Pte. Ltd.

Vertex Pharmaceuticals

446.42
-3.1000-0.69%
Volume:320.05K
Turnover:143.76M
Market Cap:113.27B
PE:31.39
High:452.63
Open:449.74
Low:446.42
Close:449.52
52wk High:519.68
52wk Low:362.50
Shares:253.72M
Float Shares:253.72M
Volume Ratio:0.57
T/O Rate:0.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):14.22
EPS(LYR):-2.0768
ROE:22.31%
ROA:12.04%
PB:6.54
PE(LYR):-214.96

Loading ...

Vertex Pharmaceuticals: Strong Buy Rating Backed by Promising Growth and Robust Pipeline

TIPRANKS
·
Oct 27

Vertex Minerals Ltd. Expands Capital with New Securities Quotation

TIPRANKS
·
Oct 27

Vertex Minerals Advances Reward Gold Mine Operations Amid Challenges

TIPRANKS
·
Oct 27

TRINASOLAR DEBUTS ELEMENTA 3, EXCLUSIVE AUSTRALIAN PANEL AT ALL ENERGY 2025

prnewswire
·
Oct 27

Vertex Presents New Data Across Portfolio of Cystic Fibrosis Medicines Including Alyftrek, at the North American Cystic Fibrosis Conference

THOMSON REUTERS
·
Oct 23

Vertex Unveils New Data on ALYFTREK and CFTR Modulators at Cystic Fibrosis Conference

Reuters
·
Oct 23

Vertex Minerals Issues Over 39 Million Options to Boost Market Position

TIPRANKS
·
Oct 23

Stifel Nicolaus Reaffirms Their Hold Rating on Vertex (VERX)

TIPRANKS
·
Oct 23

Analysts’ Top Technology Picks: Block (XYZ), Vertex (VERX)

TIPRANKS
·
Oct 22

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Oct 22

Positive Leadership Transition and Strong Earnings Drive Buy Rating for Vertex, Inc.

TIPRANKS
·
Oct 22

Vertex reported preliminary Q3 revenue $192M, consensus $191.71M

TIPRANKS
·
Oct 22

Vertex CEO retirement a surprise, says Jefferies

TIPRANKS
·
Oct 22

William Blair Sticks to Their Buy Rating for Vertex (VERX)

TIPRANKS
·
Oct 21

Press Release: Vertex Announces CEO Retirement and Succession Plan

Dow Jones
·
Oct 21

Vertex Pharmaceuticals Inc : Bofa Global Research Cuts Price Objective to $563 From $565

THOMSON REUTERS
·
Oct 21

Vertex Pharmaceuticals: Strong Market Position and Growth Potential Reinforce Buy Rating

TIPRANKS
·
Oct 21

Trinasolar and Mestron Energy Ink MOU to Strengthen Malaysia's National Energy Transition Roadmap Goals

prnewswire
·
Oct 21

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Oct 18

Goldman Sachs Cuts Vertex Pharmaceuticals Price Target to $603 From $624, Buy Rating Kept

MT Newswires Live
·
Oct 17